JP2531329B2 - 新規化合物 - Google Patents

新規化合物

Info

Publication number
JP2531329B2
JP2531329B2 JP4323052A JP32305292A JP2531329B2 JP 2531329 B2 JP2531329 B2 JP 2531329B2 JP 4323052 A JP4323052 A JP 4323052A JP 32305292 A JP32305292 A JP 32305292A JP 2531329 B2 JP2531329 B2 JP 2531329B2
Authority
JP
Japan
Prior art keywords
alkyl
amino
compound
salt
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP4323052A
Other languages
English (en)
Japanese (ja)
Other versions
JPH06321921A (ja
Inventor
洋介 桂
哲男 冨士
善一 井上
寿 高杉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of JPH06321921A publication Critical patent/JPH06321921A/ja
Application granted granted Critical
Publication of JP2531329B2 publication Critical patent/JP2531329B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP4323052A 1991-12-06 1992-12-02 新規化合物 Expired - Lifetime JP2531329B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9125970-5 1991-12-06
GB919125970A GB9125970D0 (en) 1991-12-06 1991-12-06 New compounds

Publications (2)

Publication Number Publication Date
JPH06321921A JPH06321921A (ja) 1994-11-22
JP2531329B2 true JP2531329B2 (ja) 1996-09-04

Family

ID=10705819

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4323052A Expired - Lifetime JP2531329B2 (ja) 1991-12-06 1992-12-02 新規化合物

Country Status (14)

Country Link
US (1) US5532258A (enExample)
EP (1) EP0545376B1 (enExample)
JP (1) JP2531329B2 (enExample)
CN (1) CN1079469A (enExample)
AT (1) ATE170851T1 (enExample)
AU (1) AU666893B2 (enExample)
CA (1) CA2084640A1 (enExample)
DE (1) DE69226931T2 (enExample)
GB (1) GB9125970D0 (enExample)
HU (3) HU9203849D0 (enExample)
IL (1) IL103826A0 (enExample)
MX (1) MX9206930A (enExample)
TW (1) TW211565B (enExample)
ZA (1) ZA928876B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4427539A1 (de) * 1994-08-04 1996-02-08 Sueddeutsche Kalkstickstoff Verfahren zur Herstellung von 2-Cyaniminothiazolidin
GB9416459D0 (en) * 1994-08-15 1994-10-05 Fujisawa Pharmaceutical Co New compounds
US6288091B1 (en) 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
NZ331104A (en) * 1995-12-29 2000-03-27 Boehringer Ingelheim Ca Ltd Phenyl thiazole derivatives that inhibit herpes replication by inhibiting the herpes helicase primase enzyme complex
DE19719053A1 (de) * 1997-05-06 1998-11-12 Bayer Ag Substituierte Aminothiazole
US6100282A (en) * 1998-01-02 2000-08-08 Hoffman-La Roche Inc. Thiazole derivatives
WO2003050261A2 (en) * 2001-12-10 2003-06-19 Bristol-Myers Squibb Company (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase
DE102004008141A1 (de) * 2004-02-19 2005-09-01 Abbott Gmbh & Co. Kg Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
CN116406816B (zh) * 2021-12-31 2026-03-31 湖南中烟工业有限责任公司 一种水溶性芯材烟用爆珠及其制备方法
CN116406817B (zh) * 2021-12-31 2026-03-27 湖南中烟工业有限责任公司 一种水溶性芯材烟用爆珠材料及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54132566A (en) * 1978-01-18 1979-10-15 Ici Ltd Guanidine derivative*its manufacture and secretion controlling pharmaceutical composition containing it
CA1233818A (en) * 1981-03-09 1988-03-08 David J. Gilman Guanidine derivatives as histamine h-2 receptor antagonists
IT1200371B (it) * 1982-03-24 1989-01-18 Angeli Inst Spa Guanidino eterociclifenilamidine,processi per la loro preparazione e loro impiego farmaceutico
US4452985A (en) * 1983-02-14 1984-06-05 American Home Products Corporation 2-Guanyl-4-(substituted phenyl) thiazole derivatives

Also Published As

Publication number Publication date
EP0545376A1 (en) 1993-06-09
JPH06321921A (ja) 1994-11-22
ZA928876B (en) 1993-07-15
US5532258A (en) 1996-07-02
IL103826A0 (en) 1993-04-04
EP0545376B1 (en) 1998-09-09
DE69226931D1 (de) 1998-10-15
GB9125970D0 (en) 1992-02-05
MX9206930A (es) 1993-06-01
TW211565B (enExample) 1993-08-21
HU9203849D0 (en) 1993-03-29
HU211604A9 (en) 1995-12-28
AU2983792A (en) 1993-06-10
ATE170851T1 (de) 1998-09-15
CA2084640A1 (en) 1993-06-07
DE69226931T2 (de) 1999-03-18
HUT65776A (en) 1994-07-28
AU666893B2 (en) 1996-02-29
CN1079469A (zh) 1993-12-15

Similar Documents

Publication Publication Date Title
AU656576B2 (en) Quinoline derivatives
KR0147281B1 (ko) 헤테로사이클릭 치환된 아실아미노티아졸 그 제조방법 및 그 화합물을 포함하는 약학적 조성물
JP2002513013A (ja) グアニジン誘導体
JPWO1994011375A1 (ja) 三環式化合物
JPH11349572A (ja) 新規アミド誘導体およびその塩
JPH11506468A (ja) ５−ｈｔ拮抗剤としての尿素誘導体
US7098364B2 (en) Phenylethanolamine compounds as β2-receptor agonists, and methods of use and preparation thereof
US5739130A (en) Heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them
US4591590A (en) Benzhydrylpiperazine derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
JPH06321921A (ja) 新規化合物
JP2001506995A (ja) Ｎ−ピペラジン−１−イルフェニル−ベンズアミド誘導体
US7410987B2 (en) Method for treating pain or pruritis by administering κ-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative
WO1995024395A1 (en) Quinoline derivatives as immunomodulators
JPH07224040A (ja) キノリン誘導体
JPH05194403A (ja) 複素環置換されたキノリルメトキシ−フエニルアセトアミド
JP2004002352A (ja) ２−フェニルベンゾチアゾリン誘導体からなるκオピオイド受容体アゴニスト
JPH09124633A (ja) 骨吸収抑制剤として有用なベンゾフラン誘導体およびその製造法
JPH09278767A (ja) 新規グアニジン誘導体
JPH11508588A (ja) キナゾリン誘導体
US20200039944A1 (en) Cathepsin-d and angiogenesis inhibitors and compositions thereof for treating breast cancer
JP2000504305A (ja) Ｈ▲下２▼受容体拮抗剤としての（４−（３−アミノメチルフェニル）チアゾール−２−イル）グアニジン類
JPH10158241A (ja) 尿素誘導体
JPH07100696B2 (ja) カルボスチリル誘導体
US20050154025A1 (en) Novel pyridone derivatives
JPH072873A (ja) 三環式化合物